HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction—pharmacological approaches
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- December 1999
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1110 Nursing (FoR)
- Adrenergic beta-Antagonists (MeSH)
- Angiotensin Receptor Antagonists (MeSH)
- Anticoagulants (MeSH)
- Cardiovascular Agents (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Female (MeSH)
- Heart Failure (MeSH)
- Humans (MeSH)
- Male (MeSH)
- Mineralocorticoid Receptor Antagonists (MeSH)
- Platelet Aggregation Inhibitors (MeSH)
- Systole (MeSH)
- United States (MeSH)
- Ventricular Dysfunction, Left (MeSH)
published in
- Journal of Cardiac Failure Journal